le lundi 15 octobre 2018, à 07:24. Posté
par Fabian
Very funny pictures https://www.comedyminusone.com/accupril-cvsu-1c5d.pdf#fraud accupril cvsu
The deal ends a bitter takeover saga in which Elan rejected three hostile bids by US investment firm Royalty Pharma amid injunctions, court hearings and a war of words in which Royalty Pharma said Elan was only worth $13 per share because of its "high risk strategy of hastily arranged and value destructive acquisitions".